⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL381232 | 1.00 | — | — | |
| SCHEMBL240970 | 1.00 | — | — | |
| SCHEMBL11540243 | 0.84 | TSHR (0.52) | — | |
| SCHEMBL1821872 | 0.76 | — | — | |
| SCHEMBL20756 | 0.76 | — | — | |
| SCHEMBL8564564 | 0.73 | — | — | |
| SCHEMBL17583756 | 0.73 | — | — | |
| SCHEMBL11363254 | 0.73 | — | — | |
| SCHEMBL20522695 | 0.73 | — | — | |
| SCHEMBL1130592 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106054523-B | A kind of degradable photoresist of double-response type and preparation method thereof and application method | 北京化工大学 | 2019-10-18 | — | — | CN | claimed |
| WO-2016029146-A1 | SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE | UNIVERSITY OF WASHINGTON (US) | 2016-02-25 | — | — | WO | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-1370547-B1 | BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES | PF MEDICAMENT (FR) | 2004-09-15 | — | — | EP | claimed |
| US-20040127552-A1 | Benzoaxathiepin derivatives and their use as medicines | PIERRE FABRE MEDICAMENT (FR) | 2004-07-01 | — | — | US | claimed |
| EP-1370547-A1 | BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES | PIERRE FABRE MEDICAMENT (FR) | 2003-12-17 | — | — | EP | claimed |
| WO-2002081464-A1 | BENZOAXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICINES | PIERRE FABRE MEDICAMENT (FR) | 2002-10-17 | — | — | WO | claimed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| US-12617802-B2 | Sulfonimidamide compounds as NLRP3 modulators | GENENTECH, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
| US-12424277-B2 | Electronic switching device | MERCK PATENT GMBH (DE) | 2025-09-23 | — | — | US | disclosed |
| EP-3463579-B1 | CALLYSPONGIOLIDE, ANALOGS THEREOF AND USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2025-07-16 | — | — | EP | disclosed |
| EP-4062453-B1 | ELECTRONIC SWITCHING DEVICE | MERCK PATENT GMBH (DE) | 2025-06-04 | — | — | EP | disclosed |
| EP-0536200-A1 | FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS. | MINNESOTA MINING & MFG (US) | 1993-04-14 | — | — | EP | disclosed |
| US-5087672-A | Lower birefringence and viscosity, increased hydrophobicity | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-02-11 | — | — | US | disclosed |
| WO-1991019773-A1 | FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-12-26 | — | — | WO | disclosed |
| US-4521337-A | Chemical process | BEECHAM GROUP P.L.C. (GB) | 1985-06-04 | — | — | US | disclosed |
| EP-0093485-A2 | Process for the preparation of substituted 3-oxa-1-aza-bicyclo(4.2.0)octan-8-ones, and intermediates obtained thereby | BEECHAM GROUP PLC (GB) | 1983-11-09 | — | — | EP | disclosed |
| EP-0089139-A2 | Antibiotics, their preparation and use | BEECHAM GROUP PLC (GB) | 1983-09-21 | — | — | EP | disclosed |